Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Latin America is a key pharmaceutical and healthcare market. The region's growing economies, coupled with an ageing population and increased life expectancy across the board, translate to an ever-growing demand for medicine and health-related ...
View more details
In the context of Latin America, Chile is not a particularly large pharmaceutical and healthcare market as its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...
View more details
Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...
View more details
In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...
View more details
In the past two decades, Latin America has embraced a universal health strategy, based on the principles of equity, solidarity and collective action. This strategy required steadily growing public expenditure on health in order to guarantee universal ...
View more details
In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of the incidence of communicable diseases. However, the country’s changing ...
View more details
Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the ...
View more details
In 2012-2017 Chile’s total health expenditure rose at a CAGR of 11.6%, driven by a solid increase of government spending on healthcare. In 2017, Chile allocated 8.1% of its GDP on healthcare, a figure that is bound to grow in the short term. ...
View more details
In 2015, Chile was the sixth largest pharmaceutical market in Latin America in terms of sales volume, with 278mn units sold, and the seventh biggest in terms of sales value, with USD 1.53bn, based on ex-factory prices (USD 2.32bn, based on retail ...
View more details